Sergey Lavrov mentioned that the commercial interests behind this stance were understandable, adding that one of the companies that manufactures the most popular Western jab, had already earned $30 bln
Russia laments refusal to waive patent protection for COVID-19 jabs — top diplomat
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться